Latest Novartis Group Stories
- FDA granted special use of Bexsero for nearly 20,000 UCSB students and staff in response to outbreak; the vaccine is licensed in Europe, Australia and Canada CAMBRIDGE, Mass., Feb.
-- Ultibro(TM) Breezhaler®1(QVA149), a long-term once-daily dual bronchodilator, received Health Canada approval on December 23rd 2013 for the treatment of
Reportbuyer.com just published a new market research report:
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.